Tiprelestat

DB18368InvestigationalProtein Based Therapies

Tiprelestat: Overview.

Also known as
Elastase-specific inhibitor, skin-derived antileukoproteinase, peptidase inhibitor 3 · Recombinant elafin

Resolves to

Compound
UNII78I8295690CAS820211-82-3
Targets
P08246ELANEP24158PRTN3

What you can answer from here — as of May 28, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tiprelestat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In